Evidence map›Paper›PMID 42673314›Full record

ReviewChembiochem : a European journal of chemical biology2026

Peptide Aptamers: Innovative Design and Applications in Pathogen Detection.

Shengjie Wu, Xiaoyu Wu, Jie Wen, Junwen Chen, Tonggong Liu, Dayong Gu

Abstract readReview
In one paragraph

Review in Chembiochem : a European journal of chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Peptide Aptamers: Innovative Design and Applications in Pathogen Detection.Chembiochem : a European journal of chemical biology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shengjie WuGuangxi University of Chinese Medicine, Nanning, China.
Xiaoyu WuDepartment of Laboratory Medicine, Shenzhen Key Laboratory of Medical Laboratory and Molecular Diagnostics, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen University, Shenzhen, China.
Jie WenGuangxi University of Chinese Medicine, Nanning, China.
Junwen ChenGuangxi University of Chinese Medicine, Nanning, China.
Tonggong LiuCollege of Medicine and Biological Information Engineering, Northeastern University, Shenyang, China.
Dayong GuGuangxi University of Chinese Medicine, Nanning, China.ORCID https://orcid.org/0000-0002-9547-8474

Funding

Clinical Research Special Project of the Medical and Health Technology Development Research Center of the National Health Commission WKZX2024DN0181Guangdong Science and Technology Foundation 2023B0101200003Guangdong Science and Technology Foundation 2025B1515230017Innovation Project of Guangxi Graduate Education JGY2023168Innovation Project of Guangxi Graduate Education YCSW2025437Innovation Project of Guangxi Graduate Education YCSW2026457Medical-Engineering Interdisciplinary Research Foundation of Shenzhen University 2023YG009National Health Commission Hospital Management Research Institute Project JCWJ2024ZD01National Health Commission Hospital Management Research Institute Project JYHRXZ2025B49Shenzhen High-level Hospital Construction Fund 2024WQJJ01Shenzhen Portion of Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone HTHZQSWS- KCCYB-2023060Shenzhen Science and Technology Foundation KJZD20230923115359001Shenzhen Science and Technology Foundation ZDCY20250901102000001
6 · The paper itself

Abstract

Peptide aptamers are short synthetic peptides that recognize targets with high affinity and specificity, offering advantages over antibodies and nucleic acid aptamers in size, structural flexibility, biocompatibility, and ease of chemical modification. Their design has progressed from traditional experimental screening to advanced computational approaches, such as structure-based rational design and artificial intelligence-driven generation. These methods have substantially enhanced screening efficiency and binding performance. For pathogen detection, biosensors employing peptide aptamers enable the rapid, sensitive, and specific identification of viruses, parasites, and other pathogens. Although challenges in affinity and stability remain, ongoing innovation positions peptide aptamers as a promising molecular tool for next-generation diagnostic platforms. This review systematically summarizes the design and key technological advances in peptide aptamers, emphasizing both traditional experimental screening and computer-aided design strategies. It also highlights representative applications of peptide aptamers in pathogen detection, providing a reference for developing high-performance recognition elements and novel detection platforms.

Indexed as

Aptamers, PeptideBiosensing TechniquesVirusesHumansAptamers, Peptidecomputational designpathogen detectionpeptide aptamers

Identifiers

PMID42673314
PMCPMC13529270

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.